Cell Death Differ
Dr. Aysha Khalid, MD
- Medicare services, 2024
- 35,388
- Medicare patients, 2024
- 534
- Part D claims, 2024
- 1,523
- Publications
- 14
- MIPS score, 2024
- 100
- Practice address
- 629 Cranbury Rd, East Brunswick, NJ 08816
- Practice phone
- Call (732) 390-7750
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Astera Cancer Care - East Brunswick
East Brunswick, New Jersey
Find Dr. Khalid's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Aysha Khalid is a hematologist and oncologist in East Brunswick, New Jersey
Dr. Khalid practices at Astera Cancer Care - East Brunswick in East Brunswick, New Jersey.
Dr. Khalid's NPI, 1952522732, was assigned on May 1, 2007. Dr. Khalid graduated from Ross University School of Medicine in 2001. Dr. Khalid holds New Jersey license 25MA08205500.
- NPI
- 1952522732NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4486742624
- NPI enumeration date
- May 1, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (732) 390-7750
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 51
- Medical school graduation
- 2001
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Aysha Khalid practices at Astera Cancer Care - East Brunswick in East Brunswick, New Jersey
Dr. Khalid's primary practice is Astera Cancer Care - East Brunswick, at 629 Cranbury Rd, East Brunswick, NJ 08816 in Middlesex County. The practice phone is (732) 390-7750.
- Astera Cancer Care - East Brunswick629 Cranbury Rd, East Brunswick, NJ 08816 · Middlesex CountyPhone(732) 390-7750
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Aysha Khalid is affiliated with 6 sites of care and 2 medical groups
Dr. Khalid's primary practice is Astera Cancer Care - East Brunswick in East Brunswick, New Jersey. Dr. Khalid is also affiliated with JFK University Medical Center. The medical group on file is Astera Cancer Care. Dmand AI also links Dr. Khalid to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Aysha Khalid's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khalid practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Astera Cancer Care - East Brunswick | Available with a free account |
| +5 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Aysha Khalid is one of 364 hematologists and oncologists in New Jersey
Hematology and oncology is Dr. Khalid's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Khalid is licensed in New Jersey.
Specialties and state licenses
- Hematology and oncology, New JerseyPrimary
Hematologists and oncologists near Dr. Khalid
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Aysha Khalid billed Medicare for 35,388 services in 2024
CMS data shows 35,388 Medicare services from Dr. Khalid across 25 procedure codes in 2024, for 534 Medicare patients. Medicare paid $247,596 for them.
Dr. Khalid's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 25,7432024: 31,84624%
- Office and hospital visits
- 2023: 1,6292024: 1,6994%
- Tests and treatments
- 2023: 7002024: 7243%
- Surgery
- 2023: 4082024: 51526%
- Lab and pathology
- 2023: 5102024: 5002%
- Other services
- 2023: 02024: 104
Where Dr. Khalid's Medicare services took place, 2024
- In an office34,39097%
- In a facility9983%
Dr. Khalid compared with the New Jersey median for hematologists and oncologists, 2024
- Dr. Khalid
- New Jersey median
- Medicare services
- 35,388vs 1,51523.4 times
- Medicare patients
- 534vs 33758% above
- Part D claims
- 1,156vs 3783.1 times
Medians across 349 hematologists and oncologists in New Jersey with Dmand AI profiles that report each measure.
Dr. Khalid's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Khalid?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Khalid and other hematologists and oncologists in New Jersey.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Aysha Khalid treated 534 Medicare patients in 2024, average age 76
CMS counts 534 Medicare patients who saw Dr. Khalid in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Khalid's median patient age at 67, with 67% women.
Dr. Khalid's Medicare patients by age, 2024
Dr. Khalid's Medicare patients by sex, 2024
- Women32661%
- Men20839%
Chronic conditions among Dr. Khalid's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Ischemic heart disease54%
- Diabetes52%
- Arthritis50%
- Cancer42%
- Chronic kidney disease41%
- Heart failure38%
Share of Medicare patients with each condition. A patient can have several.
Dr. Khalid's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women67%
- Men29%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Aysha Khalid wrote 1,523 Medicare Part D claims in 2024
In 2024, Dr. Khalid wrote 1,523 Medicare Part D claims for 218 patients. 66% of them were for generic drugs. CMS names the drug for 1,156 of them, across 30 drugs with 11 or more claims each, at $1,369,013 in total drug cost. In 2023, CMS named 1,083 claims across 31 drugs.
Dr. Khalid's Part D claims by kind of drug, 2024
- Generic1,010 claims66%
- Brand-name513 claims34%
Dr. Khalid's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Khalid's Part D claims, 2024
- Opioids4%60 of 1,523 claims
- Antibiotics2%35 of 1,523 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,0832024: 1,1567%
Drugs named by CMS: 30 in 2024, 31 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Aysha Khalid scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Khalid for performance year 2024, reported as part of a group. Dr. Khalid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khalid as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Khalid's MIPS scores, performance year 2024
- 100of 100Final score
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Aysha Khalid has 14 publications on record
Dmand AI links 14 papers to Dr. Khalid, published from 2016 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Osteoblasts, Osteogenesis and Cell Differentiation. Dr. Khalid has published most often in Bone. Dr. Khalid's most frequent co-authors are Jian Feng, MD, Christina Ann Gurnett, MD and Amy F. Lewanda, MD.
Dr. Khalid's papers by year, 2016 to 2024
Topics Dr. Khalid writes about most
- Osteoblasts
- Osteogenesis
- Cell Differentiation
- Core Binding Factor Alpha 1 Subunit
- Gene Expression Regulation
- Mesenchymal Stem Cells
- Osteoclasts
- Bone and Bones
Dr. Khalid's most frequent co-authors
Recent publications by Dr. Khalid
J Bone Miner Res
J Bone Miner Res
See who Dr. Khalid researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Khalid works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Aysha Khalid received $5,112 in industry payments from 2016 to 2025
CMS Open Payments shows 239 general payments to Dr. Khalid from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Bristol-Myers Squibb Company paid the most, $397.
General payments to Dr. Khalid by program year, 2016 to 2025
General payments to Dr. Khalid by kind, 2016 to 2025
- Food and beverage$4,80394%
- Education$3106%
Companies that paid Dr. Khalid the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Aysha Khalid graduated from Ross University School of Medicine
Dr. Khalid graduated from Ross University School of Medicine in 2001.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Aysha Khalid's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Aysha Khalid
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Aysha Khalid's NPI number?
Dr. Aysha Khalid's NPI number is 1952522732. It was assigned on May 1, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Aysha Khalid?
Dr. Aysha Khalid is a hematologist and oncologist in East Brunswick, New Jersey. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Aysha Khalid practice?
Dr. Khalid practices at 629 Cranbury Rd, East Brunswick, NJ 08816. Dr. Khalid's primary practice is Astera Cancer Care - East Brunswick in East Brunswick, New Jersey. Dmand AI also links Dr. Khalid to 2 hospitals, 2 group practices and clinics and 1 medical group.
What is Dr. Aysha Khalid's office phone number?
The practice phone on file for Dr. Khalid is (732) 390-7750.
What is Dr. Aysha Khalid's medical license number?
Dr. Khalid holds New Jersey license 25MA08205500.
Which hospitals is Dr. Aysha Khalid affiliated with?
Dr. Khalid is affiliated with JFK University Medical Center. Dmand AI links Dr. Khalid to 2 more hospitals.
What medical group is Dr. Aysha Khalid part of?
Dr. Khalid is linked to Astera Cancer Care. Dmand AI links Dr. Khalid to 1 more medical group.
Does Dr. Aysha Khalid accept Medicare?
Yes. CMS data shows Dr. Khalid billed Medicare for 35,388 services in 2024, and Dr. Khalid accepts Medicare assignment.
Does Dr. Aysha Khalid offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Khalid as offering telehealth services.
What is Dr. Aysha Khalid's MIPS score?
Dr. Khalid's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Aysha Khalid see?
CMS counts 534 Medicare patients who saw Dr. Khalid in 2024, with an average age of 76.
What services does Dr. Aysha Khalid bill to Medicare?
In 2024, Dr. Khalid's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J1100) and hospital inpatient care (99232).
Where did Dr. Aysha Khalid go to medical school?
Dr. Khalid graduated from Ross University School of Medicine in 2001.
What drugs does Dr. Aysha Khalid prescribe most?
In 2024 Medicare Part D data, Dr. Khalid's most prescribed drugs by claims were Anastrozole, Eliquis and Procrit.
Has Dr. Aysha Khalid received payments from drug or device companies?
CMS Open Payments shows $5,112 in general payments to Dr. Khalid from 56 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Aysha Khalid been practicing?
Dr. Khalid graduated from medical school in 2001, 25 years ago.
Does Dr. Aysha Khalid do research?
Dmand AI links 14 publications to Dr. Khalid, published from 2016 to 2024.
Who does Dr. Aysha Khalid publish with?
Dr. Khalid's most frequent co-authors are Jian Feng, MD (1 shared paper), Christina Ann Gurnett, MD (1 shared paper) and Amy F. Lewanda, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in New Jersey by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card